Impact News +++ Corporate News: innoscripta SE (EQS) +++ INNOSCRIPTA Aktie +4,44%

OPKO HEALTH Aktie

>OPKO HEALTH Aktienkurs

1.39 EUR (TradegateBSX)

Ask: 1.4 EUR / 7200 Stück

Bid: 1.38 EUR / 7300 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

OPKO HEALTH Aktie über LYNX handeln

Intraday

1 Jahr

>OPKO HEALTH Performance

1 Woche: -3,5%

1 Monat: -5,1%

3 Monate: +3,0%

6 Monate: +40,1%

1 Jahr: +6,9%

laufendes Jahr: +26,3%

>OPKO HEALTH Aktie

Profil:

OPKO Health, Inc. is a diversified healthcare company focused on diagnostics and pharmaceuticals. Through its Diagnostics segment, the company provides clinical laboratory and genetic testing services, including BioReference Health and specialized as..
>Volltext..

Insiderhandel:

>OPKO HEALTH Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>OPKO HEALTH Peer Group

Gesundheit, Nierenerkrankungen & -behandlung, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, Onkologie/ Krebs- Behandlung, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten

>OPKO HEALTH Chart & Kurs - NASDAQ

>OPKO HEALTH News

28.09.26 - 19:45	Here′s Why You Should Retain OPK Stock in Your Portfolio for Now (Zacks)
	OPKO Health eyes growth from RAYALDEE, partner revenues and a leaner BioReference, while pipeline and reimbursement risks remain key concerns....

10.09.26 - 16:31	OPKO Health: Strategiewechsel hin zu Therapeutika, gestützt durch hohe Liquidität (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

26.08.26 - 19:00	Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report? (Zacks)
	OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

19.08.26 - 20:30	OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? (Zacks)
	OPKO Health's 12.4% monthly gain is backed by narrower losses and better margins, though profitability and clinical execution remain key risks....

19.08.26 - 20:30	OPK Raises $125 Million Against Royalties: What Investors Should Know (Zacks)
	OPKO Health secured $125 million in royalty-backed financing, adding non-dilutive capital while retaining long-term exposure to mazdutide growth in China....

19.08.26 - 20:30	Is OPK Worth Buying as Valuation Meets Improving Business Trends? (Zacks)
	OPKO Health pairs a discounted forward sales multiple with narrowing losses and partnership support, but early-stage clinical risk keeps the investment case balanced....

18.08.26 - 21:15	OPKO Health Secures $125 Million Financing Against Mazdutide Royalties (Zacks)
	OPK raises $125 million against mazdutide royalties, gaining non-dilutive capital while retaining longer-term royalty upside....

04.08.26 - 19:45	OPKO Health (OPK) Upgraded to Buy: Here′s What You Should Know (Zacks)
	OPKO Health (OPK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

03.08.26 - 13:03	Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health (GlobeNewswire EN)
	Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026...

29.07.26 - 23:54	OPKO Health gives back 17% after sharp post-earnings surge (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

29.07.26 - 04:48	Top Biotech Gainers: KNSA Soars On Q2 Results, TRIB, OPK On Watch, MPLT On The Mend? (RTTNews)
	Today's top biotech gainers include Trinity Biotech, which recently completed reverse split; OPKO Health, driven by its second-quarter financial results and continued pipeline progress; Kiniksa Pharma, after raising its revenue outlook on strong commercial momentum; and MapLight Therapeutics, which staged a sharp rebound after a recent selloff, among others....

29.07.26 - 00:24	Why Opko Health Stock Surged by 33% on Tuesday (Fool)
	It posted a beat-and-raise second quarter....

28.07.26 - 20:30	OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates (Zacks)
	OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lift shares pre-market....

28.07.26 - 01:15	Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics (Zacks)
	While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

27.07.26 - 22:51	OPKO Health surges on 2026 revenue guidance boost, Q2 beats (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

27.07.26 - 22:15	OPKO Health GAAP EPS of -$0.01 beats by $0.07, revenue of $163.5M beats by $32.27M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

27.07.26 - 22:09	OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results (GlobeNewswire EN)
	Conference Call to Begin Today at 4:30 p.m. ET Conference Call to Begin Today at 4:30 p.m. ET...

26.07.26 - 23:42	OPKO Health Q2 2026 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.07.26 - 19:45	Here′s Why You Should Retain OPK Stock in Your Portfolio for Now (Zacks)
	OPKO Health's growth outlook rests on RAYALDEE, BioReference gains and partnerships, though losses and pipeline risks persist....

23.07.26 - 18:33

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026 (GlobeNewswire EN)

MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO's senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Eine gute Doktrin nützt nichts bei einem schlechten Charakter. - Sprichwort Italien

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram